Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
PlacementTracker Publishes First Half 2014 PIPE Market League Tables
-
Streetinsider.com's Hot Lunchtime Reads 07/08: (PETM) (AAPL) (CNCE) (MSFT)
-
Chardan Capital Lowers Ests on Profire Energy (PFIE) Following Equity Offering, Q4 Results
-
Chardan Capital Sees KVH Industries' (KVHI) Acquisition of Videotel as 'Significant'; Boosts Ests
-
Chardan Positive on StemCells (STEM) Following Interview with Dr. Armin Curt; Reaffirms 'Buy' Rating
-
MOKO Social Media (MOKO) IPO Opens Higher, Drifts Lower
-
Profire Energy (PFIE) Prices 6M Offering at $4/Share
-
Streetinsider.com's Hot Lunchtime Reads 06/25: (MON) (SHPG) (ADPT) (ADNC)
-
Chardan Capital Positive on Audience's (ADNC) Move to Acquire Sensor Platforms; Affirms at 'Buy'
-
Himax Technologies (HIMX) Q2 Numbers at Risk - Chardan Capital Markets
-
StemCells (STEM) Interim Phase 1/2 dry AMD Data Exceeded Expectations; Chardan Capital Keeps at 'Buy'
-
Chardan Capital Cuts PT on Endocyte (ECYT) to $15 After Regaining Vintafolide Rights
-
Chardan Positive on StemCells (STEM) into Presentation of HuCNS-SC Phase I/II Dry AMD at ISSCR
-
Chardan Capital Markets Downgrades CEVA Inc. (CEVA) to Sell
-
Himax (HIMX) Sell-Off Related to Speculation Synaptics to Acquire Renesas Display Driver Business - Chardan Capital Markets
-
LiveDeal Inc. (LIVE) Comments on 10M ATM Filing
-
Chardan Capital Market Reiterates Bullish Stance on YOU On Demand (YOD) on 'Impressive' FY14 Guidance
-
Chardan Capital Markets Upgrades The KEYW Holding Corporation (KEYW) to Buy
-
Chardan Capital Markets Starts Immune Pharmaceuticals (IMNP) at Buy, $11 PT
-
Chardan Capital Markets Downgrades Acorn Energy (ACFN) to Neutral
-
UPDATE: Chardan Capital Markets Downgrades Himax Technologies (HIMX) to Sell
-
Chardan Capital Markets Starts NanoViricides (NNVC) at Buy
-
YOU On Demand (YOD) 'In Play' Amid Alibaba Stake in Youku - Analyst
-
ECM Energy Services, Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock
-
Himax (HIMX) Target, Estimates Cut at Chardan Capital Markets
-
PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables
-
Ohr Pharmaceutical, Inc. (OHRP) Announces $18M Common Direct Placement
-
Chardan Capital Markets Starts Peregrine Semiconductor (PSMI) at Neutral
-
Montage Technology (MONT) Target Lifted at Chardan Capital Markets Amid Higher Guidance
-
Chardan Capital Markets Downgrades Magnachip Semiconductor (MX) to Neutral
-
Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...)
-
Chardan Capital Markets Lifts Price Target on Endocyte (ECYT) Sharply
-
Chardan Capital Markets Initiates Coverage on PAID, Inc. (PAYD)
-
Unusual 11 Mid-Day Movers 03/19: (DPW) (ISR) (PRTA) Higher; (CETV) (RENN) (XGTI) Lower
-
22nd Century Group (XXII) Sell-Off Creates a Buying Chance, Chardan Capital Markets Says
-
Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)
-
YOU On Demand (YOU) Price Target Hiked to $10 at Chardan Capital Markets
-
UPDATE: La Jolla Pharma (LJPC) PT Raised to $54 at Chardan
-
UPDATE: Chardan Capital Markets Starts La Jolla Pharma (LJPC) at Buy, PT $32
-
Notable Analyst Rating Changes 03/06: (BIIB) (COG) (HA) Upgraded; (AUXL) (LOV) (ARTC) Downgraded
-
Compugen (CGEN) Prices 6M Offering at $10.50/Share
-
Chardan Capital Markets Downgrades ARIAD Pharmaceuticals (ARIA) to Neutral
-
Camtek (CAMT) Target Lifted to $6 at Chardan Capital Markets on 3D Printing Opportunity
-
Montage Technology Group Limited Announces Pricing of Follow-On Public Offering
-
Notable Analyst Rating Changes 01/29: (AAL) (WMT) (ARO) Upgraded; (APOL) (RRC) (FRAN) Downgraded
-
Chardan Capital Markets Starts iPass Inc. (IPAS) at Buy, $5 Price Target
-
Notable Analyst Rating Changes 01/28: (FTNT) (MLM) (MT) Upgraded; BHI) (BCRX) (HIMX) Downgraded
-
Pre-Open Stock Movers 1/28: (CLF) (SANM) (AKS) Higher; (RCII) (CHEF) (AAPL) Lower (more...)
-
Chardan Capital Markets Downgrades Himax Technologies (HIMX) to Neutral
-
Pre-Open Stock Movers 1/21: (HEB) (YRCW) (DOW) Higher; (AMRN) (PATH) (DB) Lower (more...)

